No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
941 |
4. Check minimum number of eventsNone |
941 |
5. Include endpointsNone |
941 |
6. Filter based on genotype QC (FinnGen only) |
941 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M24
- Name in latin
- Corpus liberum articulationis
Similar endpoints
↥List of similar endpoints to
Loose body in joint
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7793 | 2490 | 5243 |
| Only index persons | 6900 | 2215 | 4685 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.12 | 0.07 | 0.15 |
| Only index persons | 0.15 | 0.08 | 0.18 |
| Median age at first event (years) | |||
| Whole population | 39.44 | 43.27 | 37.54 |
| Only index persons | 37.78 | 41.19 | 36.17 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 941 | 342 | 599 |
| Unadjusted period prevalence (%) | 0.21 | 0.12 | 0.26 |
| Median age at first event (years) | 38.93 | 39.19 | 38.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 835
- Matched controls
- 8350
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
72901
ICD-8 Finland
Other diseases of joint, Corpus liberum articuli
+∞
323.0
295
*
M24.0
ICD-10 Finland
Loose body in joint
8837.4
323.0
451
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
50.9
252.9
305
93
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
66.3
151.6
174
33
M19.0
ICD-10 Finland
Primary arthrosis of other joints
51.3
132.4
159
38
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
116.8
128.5
137
14
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
124.1
116
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
31.4
116.8
157
61
M25.5
ICD-10 Finland
Pain in joint
6.2
90.9
288
653
NCF25
NOMESCO Finland
Operation for osteochondritis of elbow joint, arthroscopic
232.9
82.9
84
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
60.6
79.0
92
17
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
13.9
78.0
139
118
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
196.5
70.2
72
*
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
15.1
67.9
116
88
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
67.6
64
*
9254
FHL
Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)
187.6
67.1
69
*
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
31.2
61.5
82
29
1220
FHL
Arthroscopy
24.1
59.3
85
39
M01AX05
ATC
glucosamine; oral
5.9
59.2
183
378
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
152.6
54.6
57
*
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
52.6
50
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
51.7
436
2168
WX320
NOMESCO Finland
Spinalanesthesy
4.4
51.6
217
619
7181B
ICD-9 Finland
Other derangement of joint, Loose body in joint[NIVELHIIRI,KYYNÄRNIVEL]
+∞
51.6
49
*
M01AH05
ATC
etoricoxib; oral
3.0
50.9
504
2785
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
9.5
50.3
108
129
N02AX02
ATC
tramadol; systemic, rectal
3.1
49.7
398
1896
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
48.4
46
*
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
135.5
48.3
51
*
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
127.1
45.2
48
*
ZXA05
NOMESCO Finland
Left side
3.5
44.0
253
929
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
56.4
40.9
48
9
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
39.9
39.2
49
13
L15
ICPC
Knee symptom/complaint
4.1
38.2
166
476
N02BE01
ATC
paracetamol; systemic, rectal
3.2
38.0
709
5323
ZXA00
NOMESCO Finland
Right side
3.2
37.6
244
963
NCF20
NOMESCO Finland
Operation for osteochondritis of elbow joint, open
372.5
36.3
36
*
1224
FHL
Arthroscopy and loose removal
372.5
36.3
36
*
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
6.8
36.2
95
154
M22.4
ICD-10 Finland
Chondromalacia patellae
193.2
36.0
37
*
1221
FHL
Arthroscopy and meniscus surgery
39.5
35.9
45
12
N02AJ06
ATC
codeine and paracetamol; systemic
2.7
35.7
321
1556
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
7.6
34.7
84
121
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
59.8
34.5
40
7
M09AX01
ATC
hyaluronic acid; parenteral
16.0
33.0
54
36
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
121.5
32.9
35
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
19.2
32.2
49
27
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
22.6
31.2
45
21
M20.1
ICD-10 Finland
Hallux valgus (acquired)
14.9
31.0
52
37
M23.8
ICD-10 Finland
Other internal derangements of knee
25.1
30.8
43
18
7181F
ICD-9 Finland
NA
+∞
30.4
29
*
M13.9
ICD-10 Finland
Arthritis, unspecified
13.4
30.2
53
42
B01AB05
ATC
enoxaparin; parenteral
2.7
30.1
250
1132
NCA30
NOMESCO Finland
Exploration of joint of elbow or forearm, arthroscopic
313.0
30.0
30
*
M01AH01
ATC
celecoxib; oral (coxibs)
3.3
27.4
151
517
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
55.3
27.3
32
6
M01AC06
ATC
meloxicam; systemic, rectal
2.4
27.2
295
1530
L90
ICPC
Osteoarthrosis of knee
13.4
26.9
47
37
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.9
26.5
117
334
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.8
26.3
197
830
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
25.1
24
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.3
25.0
323
1812
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
24.1
23
*
M01AB05
ATC
diclofenac; systemic, rectal
2.1
23.8
544
3897
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
6.8
23.4
60
94
M93.2
ICD-10 Finland
Osteochondritis dissecans
85.8
22.8
25
*
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
236.0
22.7
23
*
H02AB06
ATC
prednisolone; systemic
2.1
22.7
359
2181
M79.6
ICD-10 Finland
Pain in limb
2.3
22.6
266
1412
M24.2
ICD-10 Finland
Disorder of ligament
46.4
22.5
27
6
M02AA07
ATC
piroxicam; topical
2.2
22.0
285
1579
M19.2
ICD-10 Finland
Other secondary arthrosis
+∞
22.0
21
*
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
+∞
22.0
21
*
1223
FHL
Arthroscopy and articular cartilage surgery
118.0
21.7
23
*
M01AX17
ATC
nimesulide; oral
2.5
21.7
198
922
X58
ICD-10 Finland
Exposure to other specified factors
3.0
21.3
132
484
M23.4
ICD-10 Finland
Loose body in knee
+∞
20.9
20
*
1225
FHL
Arthroscopy and other therapeutic procedure
30.9
20.7
27
9
WX111
NOMESCO Finland
Local infiltration anesthesia
+∞
19.9
19
*
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
9.0
19.8
42
49
X59
ICD-10 Finland
Exposure to unspecified factor
2.7
19.8
154
650
B01AX06
ATC
[U] rivaroxaban; oral
75.3
19.8
22
*
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
204.5
19.6
20
*
S83.2
ICD-10 Finland
Tear of meniscus, current
4.5
19.3
70
166
72221
ICD-8 Finland
Osteochondrosis, Dissecans
71.5
18.8
21
*
M03BX02
ATC
tizanidine; oral
1.9
18.7
493
3563
M01AE01
ATC
ibuprofen; systemic, rectal
2.4
18.5
727
6156
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
4.7
18.4
64
145
M20.2
ICD-10 Finland
Hallux rigidus
45.0
18.3
22
5
M01AE02
ATC
naproxen; oral, rectal
1.9
18.2
432
2993
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.2
17.8
37
42
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
17.8
17
*
R03AC02
ATC
salbutamol; inhalant
1.9
17.8
399
2700
M22.0
ICD-10 Finland
Recurrent dislocation of patella
183.6
17.6
18
*
S18
ICPC
Laceration/cut
2.0
17.5
313
1943
ACC51
NOMESCO Finland
Release of median nerve
4.5
17.5
63
148
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
+∞
16.7
16
*
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
40.9
16.4
20
5
J01DA01
ATC
[U] cefalexin; systemic
1.8
16.4
489
3615
M03BC01
ATC
orphenadrine (citrate); systemic
2.2
16.2
193
1007
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
30.7
16.2
21
7
N03AX16
ATC
pregabalin; oral
2.3
16.1
169
833
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.0
16.0
52
110
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
5.3
16.0
49
97
A07EC01
ATC
sulfasalazine; oral, rectal
6.1
15.9
43
73
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
8.2
15.9
35
44
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.1
15.8
220
1227
NGF20
NOMESCO Finland
Operation for osteochondritis of knee, open
61.2
15.8
18
*
L89
ICPC
Osteoarthrosis of hip
16.0
15.8
25
16
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
86.7
15.6
17
*
M19.9
ICD-10 Finland
Arthrosis, unspecified
10.3
15.5
30
30
M17.5
ICD-10 Finland
Other secondary gonarthrosis
162.8
15.5
16
*
9271
FHL
Hallux surgery
162.8
15.5
16
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
15.5
115
471
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.8
15.4
52
115
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
15.3
223
1263
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
3.3
14.8
78
255
NHA30
NOMESCO Finland
Exploration of joint of ankle or foot, arthroscopic
32.3
14.8
19
6
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
21.5
14.7
21
10
7174A
ICD-9 Finland
Internal derangement of knee, Derangement of lateral meniscus
+∞
14.6
14
*
7327A
ICD-9 Finland
Osteochondropathies, Osteochondritis dissecans[OSTEOCHONDRITIS DISSECANS GENUS]
152.5
14.5
15
*
NF1AA
NOMESCO Finland
Hip X-ray examination
4.6
14.3
50
115
WX002
NOMESCO Finland
Sedation and analgesia
2.3
14.2
150
735
M01AH02
ATC
rofecoxib; oral
2.7
14.1
100
395
N03AX12
ATC
gabapentin; oral
2.6
14.1
106
435
M54.5
ICD-10 Finland
Low back pain
1.9
14.0
238
1426
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
4.1
13.9
54
138
P01BA02
ATC
hydroxychloroquine; oral
6.2
13.6
36
60
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
13.6
13
*
M24.8
ICD-10 Finland
Other specific joint derangements, not elsewhere classified
142.1
13.5
14
*
M01AB01
ATC
indometacin; systemic, rectal
3.4
13.3
65
201
SPAT1153
SPAT
Removal of sutures
1.9
13.2
224
1333
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.4
13.2
116
520
R4110
NOMESCO Finland
Physiotherapy
2.0
12.9
199
1143
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
50.8
12.9
15
*
J01AA02
ATC
doxycycline; systemic
1.8
12.7
597
4888
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
32.6
12.6
16
5
72908
ICD-8 Finland
Other diseases of joint, Alii definiti
32.6
12.6
16
5
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
7.5
12.6
29
40
WX200
NOMESCO Finland
Interscalenous plexus blockade
9.2
12.3
25
28
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
12.1
119
565
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.7
12.1
52
146
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
6.6
11.9
30
47
J01FA10
ATC
azithromycin; systemic
1.7
11.9
419
3126
M01AE11
ATC
tiaprofenic acid; oral, rectal
4.9
11.9
38
80
M48.0
ICD-10 Finland
Spinal stenosis
2.6
11.6
84
339
NHE15
NOMESCO Finland
Suture or reinsertion of ligament of ankle
19.2
11.6
17
9
NG2AA
NOMESCO Finland
Patella X-ray examination
23.2
11.6
16
7
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
11.5
11
*
7151B
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, KYYNÄRNIVEL]
+∞
11.5
11
*
A02BC02
ATC
pantoprazole; systemic
1.7
11.5
471
3653
NHF20
NOMESCO Finland
Operation for debridement of ankle joint, open
121.5
11.4
12
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
11.4
178
1023
L08
ICPC
Shoulder symptom/complaint
2.1
11.3
131
667
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
15.3
11.3
18
12
M67.4
ICD-10 Finland
Ganglion
3.5
11.3
53
160
NG1DA
NOMESCO Finland
X-ray of knees
35.5
11.3
14
*
WX110
NOMESCO Finland
Local anesthesy
1.7
11.0
518
4148
B01AF01
ATC
rivaroxaban; oral
2.7
11.0
75
290
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
43.9
10.9
13
*
WX702
NOMESCO Finland
Supraglottic ventilation device
3.7
10.7
46
130
J01DB01
ATC
cefalexin; oral
1.7
10.6
629
5342
M22.1
ICD-10 Finland
Recurrent subluxation of patella
111.3
10.4
11
*
9521
FHL
Arthrotomy (eg loose removal)
+∞
10.4
10
*
7151E
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, LONKKANIVEL]
+∞
10.4
10
*
ND1CG
NOMESCO Finland
Wrist and hand extensive MRI examination with high intensity magnet
32.9
10.3
13
*
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
10.3
207
1293
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.1
10.3
55
184
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
23.7
10.3
14
6
A02BC05
ATC
esomeprazole; systemic
1.7
10.2
276
1889
G56.2
ICD-10 Finland
Lesion of ulnar nerve
4.0
9.9
39
102
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.1
9.8
54
184
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
26.3
9.8
13
5
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
20.3
9.8
14
7
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
10.8
9.8
18
17
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
10.8
9.8
18
17
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
3.7
9.7
42
119
R03DC03
ATC
montelukast; oral
2.1
9.6
109
550
NC1BG
NOMESCO Finland
Elbow MRI examination with high intensity magnet
30.4
9.4
12
*
73799
ICD-8 Finland
Hallux valgus and varus
+∞
9.4
9
*
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
+∞
9.4
9
*
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
22.0
9.4
13
6
A02BC03
ATC
lansoprazole; oral
1.7
9.3
201
1280
S83.0
ICD-10 Finland
Dislocation of patella
7.4
9.3
21
29
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.6
9.1
65
261
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
18.8
8.9
13
7
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
8.9
71
303
M94.2
ICD-10 Finland
Chondromalacia
24.3
8.9
12
5
M15
ICD-10 Finland
Polyarthrosis
4.8
8.8
28
60
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
6.2
8.7
22
36
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
16.5
8.6
13
8
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
9.1
8.6
17
19
L01
ICPC
Neck symptom/complaint
2.2
8.5
86
412
L16
ICPC
Ankle symptom/complaint
2.6
8.5
62
253
M01AB55
ATC
diclofenac, combinations; oral
3.0
8.5
48
166
M23.5
ICD-10 Finland
Chronic instability of knee
90.9
8.4
9
*
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
4.9
8.4
26
54
WZA90
NOMESCO Finland
Other doctors statement
1.8
8.4
152
911
NBE45
NOMESCO Finland
Plastic repair of ligament of shoulder not using prosthetic material, arthroscopic
12.9
8.4
14
11
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
12.9
8.4
14
11
7176A
ICD-9 Finland
Internal derangement of knee, Loose body in knee
+∞
8.3
8
*
7152F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, secondary[OSTEORTHROSIS SECUNDARIA,POLVI]
+∞
8.3
8
*
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
9.6
8.3
16
17
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.3
8.2
77
358
M19.8
ICD-10 Finland
Other specified arthrosis
6.1
8.2
21
35
R06AE09
ATC
levocetirizine; oral
2.0
8.1
100
521
M54.2
ICD-10 Finland
Cervicalgia
2.8
8.1
51
190
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
5.1
8.1
24
48
WZA00
NOMESCO Finland
Short statement of of health and health related matters
3.2
8.0
40
129
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
13.2
7.9
13
10
WX204
NOMESCO Finland
Axillary plexus blockaced
4.4
7.9
27
63
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.3
7.8
38
120
8360A
ICD-9 Finland
Dislocation of knee, Tear of medial cartilage or meniscus of knee, current
10.9
7.8
14
13
M23.3
ICD-10 Finland
Other meniscus derangements
15.2
7.7
12
8
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
45.4
7.7
9
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
45.4
7.7
9
*
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
45.4
7.7
9
*
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
4.0
7.7
29
74
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
7.5
7.7
17
23
S83.4
ICD-10 Finland
Sprain and strain involving (fibular)(tibial) collateral ligament of knee
4.3
7.6
27
65
R05FB02
ATC
cough suppressants and expectorants
1.6
7.6
260
1865
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
10.1
7.5
14
14
M01AB08
ATC
etodolac; oral
2.7
7.5
49
188
NG1AA
SPAT
NA
3.5
7.5
33
97
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
80.7
7.4
8
*
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
80.7
7.4
8
*
9294
FHL
Endoprosthesis replacement of the entire hip joint (eg Charnley)
80.7
7.4
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
7.4
289
2135
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.1
7.4
39
131
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
7.3
71
335
SFA00
NOMESCO Finland
Small filling
2.0
7.3
92
484
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
+∞
7.3
7
*
212
Kela drug reimbursment
Gout
+∞
7.3
7
*
9314
FHL
Total knee endoprosthesis (also includes patellar part)
+∞
7.3
7
*
M25.8
ICD-10 Finland
Other specified joint disorders
+∞
7.3
7
*
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
+∞
7.3
7
*
NCF10
NOMESCO Finland
Synovectomy of elbow joint, open
+∞
7.3
7
*
NGB10
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, demi prosthesis
+∞
7.3
7
*
M17.2
ICD-10 Finland
Post-traumatic gonarthrosis, bilateral
+∞
7.3
7
*
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
7.3
7
*
NH1AD
NOMESCO Finland
Ankle and foot CT
6.3
7.3
18
29
9255
FHL
Joint auger removal
15.9
7.2
11
7
9243
FHL
Plastic of the patella and its tendons
15.9
7.2
11
7
84400
ICD-8 Finland
Sprains and strains of knee and leg
7.4
7.2
16
22
S93.2
ICD-10 Finland
Rupture of ligaments at ankle and foot level
7.4
7.2
16
22
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
7.2
185
1233
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
30.3
7.2
9
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
20.2
7.1
10
5
S83.5
ICD-10 Finland
Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
3.6
7.0
30
86
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
7.0
378
2988
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
7.0
503
4220
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
6.9
278
2059
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
6.9
117
686
ACC53
NOMESCO Finland
Release of ulnar nerve
5.9
6.9
18
31
L10
ICPC
Elbow symptom/complaint
3.0
6.9
37
126
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
6.9
118
693
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.7
6.9
136
839
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
6.8
6.8
16
24
SPAT1210
SPAT
Application of cast or individual aid
3.7
6.8
28
78
S53.4
ICD-10 Finland
Sprain and strain of elbow
11.0
6.8
12
11
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
6.8
265
1950
M25.2
ICD-10 Finland
Flail joint
40.4
6.8
8
*
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
40.4
6.8
8
*
L04AA13
ATC
leflunomide; oral
16.8
6.8
10
6
Z50.1
ICD-10 Finland
Other physical therapy
3.1
6.7
35
117
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.7
193
1317
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.2
6.7
67
322
R06.0
ICD-10 Finland
Dyspnoea
1.7
6.7
154
991
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
6.7
335
2603
M35.7
ICD-10 Finland
Hypermobility syndrome
12.4
6.6
11
9
H02BX01
ATC
methylprednisolone, combinations; systemic
3.0
6.6
36
125
M77.1
ICD-10 Finland
Lateral epicondylitis
2.4
6.6
53
230
E883A
ICD-9 Finland
Fall into hole or other opening in surface
2.7
6.5
42
159
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
6.5
266
1970
R06AE07
ATC
cetirizine; oral
1.5
6.5
283
2124
L88
ICPC
Rheumatoid/seropositive arthritis
6.9
6.5
15
22
R05
ICPC
Cough
1.7
6.4
132
821
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
70.3
6.4
7
*
TNX30
NOMESCO Finland
Soft bandage, unspecified region
7.5
6.4
14
19
L12
ICPC
Hand/finger symptom/complaint
2.0
6.4
82
436
UJF32
NOMESCO Finland
Coloscopy
1.6
6.4
162
1071
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
14.4
6.4
10
7
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
6.4
354
2797
J01FA06
ATC
roxithromycin; oral
1.5
6.4
274
2056
NBL22
NOMESCO Finland
Myotomy, tenotomy or excision of tendon of upper arm
6.6
6.3
15
23
G47.3
ICD-10 Finland
Sleep apnoea
1.6
6.3
157
1032
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
6.3
108
635
M65.3
ICD-10 Finland
Trigger finger
3.4
6.3
28
84
1222
FHL
Arthroscopy and synovial surgery
18.2
6.3
9
5
NDA30
NOMESCO Finland
Exploration of joint of wrist or hand, arthroscopic
18.2
6.3
9
5
S22.3
ICD-10 Finland
Fracture of rib
2.3
6.3
53
234
RF210
NOMESCO Finland
NA
4.4
6.3
21
49
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
6.3
6
*
71308
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) alia (spinali excepta)
+∞
6.3
6
*
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
+∞
6.3
6
*
7183F
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, POLVI]
+∞
6.3
6
*
NCF15
NOMESCO Finland
Synovectomy of elbow joint, arthroscopic
+∞
6.3
6
*
M79.7
ICD-10 Finland
Fibromyalgia
4.8
6.2
19
40
M23
ICD-10 Finland
Internal derangement of knee
4.8
6.2
19
40
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
6.2
139
889
WX290
NOMESCO Finland
Other blockade of nerve
1.5
6.1
308
2382
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.1
384
3102
S89.9
ICD-10 Finland
Unspecified injury of lower leg
3.8
6.1
24
65
M35.3
ICD-10 Finland
Polymyalgia rheumatica
3.8
6.1
24
65
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
6.1
105
620
M01AC01
ATC
piroxicam; systemic, rectal
1.9
6.1
94
533
R06AX27
ATC
desloratadine; oral
1.6
6.1
174
1183
Z01.2
ICD-10 Finland
Dental examination
1.5
6.1
274
2068
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
6.1
40
156
9057A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of sprain and strain without mention of tendon injury
10.1
6.0
11
11
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.2
6.0
21
51
H02AB04
ATC
methylprednisolone; systemic
1.9
6.0
92
523
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
6.0
444
3695
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021788) Differential panel - Synovial fluid
34
22
16.00
39.30
1.6
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
39
41
9.88
33.46
1.5
1.1
e6/l
5339.5
18344.5
0.93
22
30
(3044941) Cell count panel - Synovial fluid
33
32
10.65
29.92
1.5
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
188
793
2.71
29.76
1.3
1.2
iu/ml
25.8
15.5
0.92
53
218
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
37
52
7.37
25.16
1.2
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
292
1637
2.14
23.69
2.3
2.4
umol/l
6103.7
8704.3
0.37
259
1437
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
166
742
2.50
22.93
1.3
1.1
u/ml
7.5
1.5
0.86
60
311
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
19
17
11.39
18.03
1.6
1.0
%
52.5
74.8
1.04
12
11
(3013707) Erythrocyte sedimentation rate by Westergren method
630
4883
1.88
17.84
4.4
3.0
mm/h
10.6
11.2
0.45
598
4481
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
431
3051
1.76
15.79
3.8
3.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
447
3411
1.59
10.90
6.1
5.2
e9/l
1.9
1.9
0.10
397
2956
(3013115) Eosinophils [#/volume] in Blood
450
3444
1.59
10.80
6.2
5.5
e9/l
0.2
0.2
0.37
398
2972
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
33
90
3.76
10.76
1.5
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
809
7187
1.90
10.55
14.7
12.7
mg/l
20.8
26.9
6.91
663
5507
(3006315) Basophils [#/volume] in Blood
435
3316
1.58
10.53
6.2
5.2
e9/l
0.0
0.0
0.22
382
2828
(3001604) Monocytes [#/volume] in Blood
431
3302
1.56
10.06
6.2
5.2
e9/l
0.6
0.6
0.62
379
2811
(3042936) Bacteria identified in Isolate by Culture
145
868
1.79
8.79
1.8
2.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
835
7591
1.89
8.76
15.7
15.2
mmol/l
4.0
4.0
0.38
817
7354
(3002030) Lymphocytes/100 leukocytes in Blood
417
3239
1.52
8.75
6.0
5.4
%
28.5
27.5
1.07
398
3018
(3008898) HLA-B27 [Presence]
42
153
2.83
8.65
1.1
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
404
3130
1.51
8.52
6.0
5.4
%
2.7
2.9
0.67
384
2911
(3010144) Erythrocytes [#/volume] in Synovial fluid
13
19
6.92
8.46
1.2
1.0
e6/l
117867.0
43056.0
—
7
11
(40760892) CBC W Ordered Manual Differential panel - Blood
221
1501
1.62
8.36
5.1
4.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
830
7555
1.84
8.33
15.6
15.1
mmol/l
139.7
139.7
0.41
811
7333
(3019069) Monocytes/100 leukocytes in Blood
404
3147
1.50
8.21
6.2
5.7
%
8.4
8.8
1.71
385
2947
(3018010) Neutrophils/100 leukocytes in Blood
408
3185
1.50
8.20
5.7
5.3
%
57.0
57.4
0.30
390
2981
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
621
5282
1.52
8.16
7.3
7.4
u/l
76.1
78.0
0.48
590
4993
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
214
1452
1.61
8.11
1.5
1.7
mg/l
0.9
1.3
2.04
152
1085
(3013650) Neutrophils [#/volume] in Blood by Automated count
484
3926
1.48
7.95
8.4
8.8
e9/l
4.1
4.2
0.29
428
3401
(3037522) Nuclear Ab [Titer] in Serum
118
689
1.81
7.74
1.3
1.3
titre
288.7
451.2
0.68
23
114
(3044889) 12 lead EKG panel
600
5104
1.48
7.58
3.9
3.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
389
3043
1.47
7.56
6.0
5.4
%
0.6
0.7
0.33
370
2837
(3018095) Leukocytes [#/volume] in Urine
312
2338
1.50
7.49
3.7
3.4
e6/l
112.4
136.5
0.18
231
1680
(3021601) Nitrite [Presence] in Urine by Test strip
410
3250
1.46
7.40
4.9
4.3
estimate
0.0
0.0
0.50
86
586
(3035350) Ketones [Presence] in Urine by Test strip
410
3258
1.46
7.26
3.6
3.1
estimate
0.0
0.0
0.00
84
573
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
856
7932
1.88
7.19
10.1
9.0
u/l
27.9
28.0
0.09
836
7641
(3009261) Glucose [Presence] in Urine by Test strip
412
3289
1.45
7.06
3.7
3.1
estimate
0.0
0.0
0.47
82
552
(3037467) Urinalysis macro (dipstick) panel - Urine
551
4649
1.45
6.98
4.4
3.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
258
1887
1.51
6.87
3.6
4.1
ph
7.4
7.4
0.36
55
384
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
90
504
1.87
6.74
2.7
2.5
ml/min/173m2
60.5
67.5
1.11
33
194
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
38
151
2.58
6.67
1.6
1.5
iu/ml
0.1
0.0
—
7
26
(3017181) Myelocytes/100 leukocytes in Blood
90
508
1.85
6.58
4.1
4.5
%
0.9
0.9
0.03
23
166
(3011397) Hemoglobin [Presence] in Urine by Test strip
202
1418
1.54
6.48
3.4
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
276
2068
1.47
6.46
2.1
2.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
834
7728
1.70
6.21
13.2
12.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
317
2460
1.44
6.11
3.3
3.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
288
2200
1.45
6.03
5.9
5.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
84
478
1.83
6.00
4.1
4.6
%
0.1
0.2
0.20
20
152
(3002385) Erythrocyte distribution width [Ratio]
683
6090
1.44
5.80
16.9
15.7
%
13.7
13.6
0.44
669
5940
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
744
6751
1.49
5.70
5.4
5.4
mmol/mol
40.0
40.0
0.03
706
6238
(3002582) Erythrocytes [#/volume] in Urine
269
2051
1.44
5.63
3.1
3.0
e6/l
30.8
65.7
2.00
218
1579
(3002179) Metamyelocytes/100 leukocytes in Blood
81
465
1.81
5.63
4.2
4.3
%
0.2
0.6
1.92
15
118
(3031040) Bacteria [#/volume] in Urine by Automated count
515
4389
1.38
5.59
4.5
3.8
e6/l
10.8
2135.4
—
5
81
(3030467) Casts [#/volume] in Urine by Automated count
244
1829
1.45
5.59
3.0
3.0
e6/l
0.3
0.5
0.45
189
1365
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
764
6978
1.50
5.58
13.6
11.9
ml/min/173m2
82.5
82.7
0.12
664
5673
(36304419) Bacteria [Presence] in Urine
240
1794
1.45
5.58
3.0
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
335
2678
1.39
5.29
3.6
3.4
ng/l
37.7
77.0
1.15
219
1844
(3025159) Blasts/100 leukocytes in Blood
78
452
1.79
5.27
4.3
4.6
%
0.0
0.1
1.21
15
129
(3013826) Glucose [Moles/volume] in Serum or Plasma
490
4169
1.37
5.23
4.3
5.1
mmol/l
6.7
6.8
1.05
466
3885
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
364
2954
1.38
5.23
5.2
6.6
mmol/l
1.2
1.2
0.66
340
2671
(3024561) Albumin [Mass/volume] in Serum or Plasma
358
2898
1.38
5.23
3.5
5.2
g/l
36.2
35.6
1.27
335
2694
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
110
705
1.63
5.16
3.2
3.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
878
8339
1.79
4.83
21.1
18.3
e9/l
248.6
245.3
0.75
859
8082
(3024731) MCV [Entitic volume]
878
8344
1.78
4.75
21.0
18.3
fl
91.2
90.8
1.86
867
8190
(3035941) MCH [Entitic mass]
878
8345
1.78
4.74
21.0
18.2
pg
30.5
30.4
1.47
867
8190
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
318
2558
1.37
4.72
2.3
2.1
nmol/l
78.3
74.7
1.59
286
2302
(3026361) Erythrocytes [#/volume] in Blood
878
8346
1.78
4.72
21.1
18.3
e12/l
4.6
4.6
0.38
854
8074
(3000963) Hemoglobin [Mass/volume] in Blood
878
8349
1.77
4.67
21.3
18.4
g/l
138.1
138.2
0.05
869
8195
(3010813) Leukocytes [#/volume] in Blood
878
8350
1.77
4.66
21.1
18.4
e9/l
6.8
6.7
0.47
856
8074
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
149
1057
1.49
4.46
1.6
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
123
844
1.53
4.32
23.9
21.4
inr
1.2
1.4
0.59
17
114
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
795
7415
1.47
4.32
4.3
4.2
mmol/l
4.6
4.6
0.39
752
6882
(3029937) Albumin [Presence] in Urine by Test strip
227
1751
1.39
4.31
4.0
3.3
estimate
0.0
0.0
1.34
86
561
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
388
3251
1.33
4.31
5.5
7.3
mmol/l
1.2
1.2
2.00
321
2722
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
773
7179
1.43
4.23
4.5
4.2
mmol/l
6.0
6.0
0.38
716
6568
(3000492) Spirometry study
106
707
1.56
4.23
1.5
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
215
1651
1.39
4.18
5.7
6.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
806
7549
1.47
4.17
4.8
4.6
mmol/l
2.7
2.8
0.62
755
6960
(3000850) Epithelial cells [#/volume] in Urine
187
1403
1.42
4.16
2.3
2.4
e6/l
4.3
5.2
0.44
164
1230
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
789
7362
1.44
4.14
4.2
4.1
mmol/l
1.4
1.4
0.82
747
6778
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
168
2.13
4.12
1.6
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
563
4992
1.32
4.09
2.8
3.0
u/l
49.4
52.9
0.42
534
4688
(3001122) Ferritin [Mass/volume] in Serum or Plasma
345
2863
1.32
4.03
2.5
2.6
ug/l
148.1
157.8
0.24
321
2652
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
205
1573
1.39
3.99
2.0
2.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
705
6479
1.35
3.86
4.3
4.1
mu/l
1.8
2.1
0.74
645
5879
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
150
1099
1.43
3.79
2.8
2.7
e6/l
0.7
0.9
0.70
84
612
(3021589) Normoblasts [#/volume] in Blood
366
3092
1.30
3.68
10.0
8.6
e9/l
0.0
0.0
0.32
305
2499
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
515
4555
1.29
3.61
3.1
2.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
25
111
2.29
3.57
1.8
1.9
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
15
52
2.92
3.47
1.1
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
143
1062
1.41
3.35
3.0
2.8
e6/l
1.3
1.8
0.45
77
579
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
759
7106
1.35
3.30
3.8
3.8
mmol/l
1.3
1.3
0.59
717
6517
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
416
3613
1.27
3.25
5.0
6.9
umol/l
11.2
12.4
1.65
392
3454
(3024263) Appearance of Synovial fluid
7
11
6.40
3.19
1.0
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
309
2593
1.29
3.17
3.9
3.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
734
6854
1.32
3.13
14.5
13.6
%
40.8
40.6
0.20
549
5031
(3017732) Neutrophils [#/volume] in Blood
66
424
1.60
3.13
2.0
3.5
e9/l
4.1
4.1
0.06
52
328
(3026782) Osmolality of Urine
174
1353
1.35
3.08
2.7
2.5
mosm/kgh2o
539.4
561.6
0.68
143
1147
(4010399)
73
485
1.55
3.01
1.4
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
332
2830
1.27
2.97
9.9
9.0
inr
1.2
1.3
0.27
104
832
(3026008) Bacteria identified in Urine by Culture
217
1755
1.31
2.92
3.4
2.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
63
411
1.57
2.82
2.4
2.3
au/ml
17.8
20.4
—
9
23
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
229
1874
1.29
2.82
2.8
3.1
ng/l
1459.2
1461.4
0.00
183
1586
(3045414) Leukocytes [Presence] in Urine
43
256
1.71
2.75
1.7
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
19
85
2.26
2.71
1.1
1.4
nmol/l
0.5
0.6
0.40
19
80
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
10
6.03
2.70
1.7
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
76
525
1.49
2.64
3.7
3.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
383
3358
1.24
2.59
5.0
4.6
ug/l
2.3
2.9
0.83
353
3005
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
121
2.01
2.57
5.1
3.3
%
57.1
58.0
0.09
24
121
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
172
1375
1.31
2.51
3.2
3.5
ng/l
307.1
556.6
0.93
124
1050
(3019150) Specific gravity of Urine by Refractometry
180
1448
1.30
2.51
4.0
3.2
kg/l
1.0
1.0
0.35
25
192
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
257
2163
1.26
2.50
2.5
2.6
u/l
59.7
57.8
0.12
236
2014
(3048689) Calprotectin [Mass/mass] in Stool
101
749
1.39
2.42
2.7
2.4
ug/g
98.3
153.2
2.16
80
602
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
238
1992
1.26
2.42
2.4
2.1
u/l
174.9
275.6
1.37
228
1879
(3033658) Prothrombin time (PT) actual/Normal
216
1795
1.26
2.32
3.3
3.9
%
85.9
89.0
0.96
210
1754
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
233
1956
1.25
2.30
2.8
2.8
ug/l
0.9
0.8
0.35
158
1257
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
63
434
1.48
2.25
4.7
8.9
mmol/l
24.7
24.7
0.01
63
429
(3015235) Bicarbonate [Moles/volume] in Capillary blood
32
187
1.74
2.23
2.3
2.9
mmol/l
24.3
25.0
0.36
24
169
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
195
1610
1.27
2.21
2.1
2.0
mg/l
3.1
2.9
0.89
170
1350
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
169
1373
1.28
2.18
1.3
1.2
u/ml
1.0
2.0
1.11
53
361
(3023368) Bacteria identified in Blood by Culture
224
1884
1.25
2.17
3.9
4.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
47
307
1.56
2.15
2.4
2.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
116
1.92
2.12
5.2
2.8
e9/l
4.1
4.4
0.45
22
116
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
31
2.92
2.07
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
10
5.02
2.07
2.0
2.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
128
1012
1.31
2.04
1.9
2.5
umol/l
14.1
13.8
0.13
118
935
(3011412) CD3 cells [#/volume] in Blood
12
50
2.42
2.03
4.8
2.2
e9/l
1.4
1.2
—
7
28
(3003338) MCHC [Mass/volume]
681
6417
1.22
2.02
18.1
16.1
g/l
334.1
333.7
0.43
674
6362
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
9
32
2.83
2.00
5.7
7.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
310
2719
1.21
1.99
4.0
4.1
%
23.3
21.9
0.80
151
1321
(40768797) Stomach Pathology biopsy report
113
882
1.32
1.98
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
202
1.66
1.98
2.1
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
101
776
1.34
1.97
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
271
2350
1.22
1.95
2.9
3.3
u/l
31.3
34.2
0.96
253
2244
(3027008) Opiates [Presence] in Urine
41
268
1.55
1.90
2.0
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
78
579
1.38
1.90
4.0
3.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
79
2.04
1.86
1.1
1.4
nmol/l
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
256
2217
1.21
1.86
3.1
3.1
mmol/l
8.3
8.1
0.30
221
1868
(3028300) Cannabinoids [Presence] in Urine
41
270
1.54
1.84
1.9
2.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
60
431
1.42
1.77
2.8
3.4
kpa
5.2
5.2
0.32
52
405
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
132
1.76
1.75
1.0
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
40
267
1.52
1.71
1.9
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
37
243
1.54
1.70
1.9
2.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
15
75
2.02
1.70
1.3
1.4
pmol/l
368.3
319.8
—
10
63
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
87
670
1.33
1.69
1.3
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
117
939
1.28
1.69
1.8
2.5
g/l
2.3
2.3
0.56
107
880
(3009343) pH of Capillary blood
59
427
1.41
1.68
2.8
3.4
ph
7.4
7.4
—
5
54
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
18
97
1.87
1.67
1.1
1.2
—
47.1
—
0
8
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
18
97
1.87
1.67
1.7
3.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
31
2.59
1.66
4.8
3.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
25
2.81
1.65
2.1
2.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
96
754
1.30
1.63
1.5
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
110
880
1.28
1.63
1.8
2.6
%
23.6
23.8
0.05
98
757
(40768804) Tissue Pathology biopsy report
310
2762
1.18
1.63
2.3
2.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
297
2639
1.18
1.61
2.0
1.9
pmol/l
97.8
91.9
1.55
169
1424
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
20
3.01
1.58
3.5
2.1
ug/l
60.2
51.7
—
6
20
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
20
3.01
1.58
2.3
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
152
1.66
1.58
1.4
1.7
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
254
2231
1.19
1.57
2.5
3.7
mmol/l
2.3
2.3
0.08
239
1977
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
168
1.63
1.56
1.6
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
33
2.44
1.54
4.4
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
39
267
1.48
1.51
2.1
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
175
1490
1.21
1.50
1.4
1.5
nmol/l
20.0
20.0
0.01
148
1270
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
125
0.40
1.50
1.8
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
147
1231
1.23
1.49
1.4
1.4
g/l
2.4
2.5
0.30
92
797
(3038177) Helicobacter pylori Ab [Presence] in Serum
21
124
1.71
1.48
1.3
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
45
319
1.43
1.47
3.1
3.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
146
1225
1.23
1.45
2.1
3.3
mmol/l
2.4
2.4
0.34
135
1082
(3017446) Testosterone [Moles/volume] in Serum or Plasma
89
705
1.29
1.44
2.0
2.1
nmol/l
11.1
13.6
1.87
78
625
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
71
546
1.32
1.43
3.5
3.6
mmol/l
1.2
1.2
0.24
63
472
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
33
221
1.51
1.42
2.0
2.4
g/l
3.0
3.0
0.00
28
171
(3022621) pH of Urine by Test strip
53
390
1.38
1.41
3.1
2.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
7
29
2.42
1.39
1.6
2.6
ug/l
22.9
17.8
—
7
24
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
15
82
1.84
1.36
1.1
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
17
2.95
1.36
2.0
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
29
192
1.53
1.33
3.5
3.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
111
915
1.24
1.31
3.8
6.1
mmol/l
1.0
1.0
0.48
104
848
(3012501) Base excess in Blood by calculation
25
161
1.57
1.29
2.9
4.1
mmol/l
1.5
2.4
2.05
16
114
(3004451) EKG impression Narrative
8
34
2.36
1.29
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
31
210
1.49
1.29
1.5
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
133
0.45
1.28
1.2
1.3
—
—
—
0
0
(4211845)
5
18
2.79
1.28
1.6
2.1
—
—
—
0
0
(3020891) Body temperature
42
303
1.40
1.27
3.4
4.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
19
115
1.67
1.25
1.1
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
8
36
2.23
1.24
3.4
2.2
e9/l
0.1
0.2
—
8
36
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
36
2.23
1.24
1.8
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
171
1.54
1.24
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
211
1861
1.17
1.23
1.6
1.7
mmol/l
1.5
1.4
0.25
178
1546
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
238
1.44
1.22
2.0
2.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
34
238
1.44
1.22
2.0
2.4
g/l
3.7
3.7
0.05
27
169
(3003129) Base excess in Capillary blood by calculation
5
19
2.64
1.21
1.4
1.5
mmol/l
-1.6
2.4
—
5
19
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
93
1.73
1.21
1.2
1.0
u/ml
9.1
1.8
—
8
37
(36660697) Celiac disease serology panel - Serum
62
482
1.31
1.19
1.2
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
24
157
1.54
1.18
2.5
3.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
456
1.31
1.18
3.0
4.0
ng/l
78.6
90.2
0.93
54
398
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
33
0.00
1.16
0.0
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
33
0.00
1.16
0.0
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
20
2.51
1.15
4.4
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
34
242
1.42
1.13
1.7
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
113
0.44
1.13
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
113
0.44
1.13
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
113
0.44
1.13
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
113
0.44
1.13
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
210
1865
1.16
1.13
3.5
2.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
48
363
1.34
1.12
1.5
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
10
51
1.97
1.11
2.7
1.8
—
—
—
0
0
(3013512) EKG study
224
2002
1.16
1.10
3.9
3.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
90
741
1.24
1.10
6.0
10.0
%
95.2
95.4
0.15
85
719
(3012516) Albumin [Mass/volume] in Urine
230
2063
1.15
1.08
3.1
3.2
mg/l
316.0
309.9
0.01
150
1339
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
100
835
1.22
1.08
7.0
6.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
227
2035
1.15
1.07
1.5
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
64
508
1.28
1.07
2.1
2.9
g/l
66.6
66.3
0.13
59
467
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
97
1.66
1.07
1.1
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
92
763
1.23
1.06
3.8
4.4
u/l
259.3
246.3
0.22
84
725
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
53
411
1.31
1.05
2.7
3.4
mmol/l
2.3
1.8
0.37
33
303
(3028626) Oxygen [Partial pressure] in Capillary blood
23
154
1.51
1.04
2.5
2.8
kpa
8.5
8.1
0.76
18
144
(3016228) CD19 cells/100 cells in Blood
5
22
2.28
1.03
1.6
1.7
%
6.0
7.9
—
5
22
(21494814) CD8 cells/100 lymphocytes in Specimen
5
22
2.28
1.03
1.6
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
34
2.07
1.03
1.3
1.0
miu/ml
1234.3
1745.7
—
7
34
(3002256) Pathology report gross observation
107
905
1.21
1.02
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
116
989
1.20
1.02
1.4
1.9
%
1.5
1.5
0.00
103
883
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
50
387
1.31
1.02
8.6
14.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
17
107
1.60
1.00
1.1
1.2
u/ml
1.8
6.3
—
5
39
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
552
5254
1.12
0.99
3.8
3.5
pmol/l
14.7
14.8
0.23
505
4752
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
61
1.81
0.98
1.0
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
462
1.27
0.96
1.1
1.6
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
97
819
1.21
0.95
5.9
9.6
kpa
11.9
12.2
0.23
90
787
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
97
819
1.21
0.95
5.9
9.6
kpa
5.0
5.1
0.38
91
784
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
13
77
1.70
0.95
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
57
709
0.79
0.95
4.0
4.6
ug/l
8.5
26.3
0.94
47
605
(3007853) Bacteria identified in Skin by Aerobe culture
90
755
1.21
0.95
1.9
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
209
0.62
0.94
1.6
1.6
—
—
—
0
0
(4027681)
7
37
1.90
0.94
1.1
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
101
1.59
0.94
1.1
1.2
u/ml
1.5
4.3
—
6
53
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
63
1.75
0.90
1.4
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
143
1.48
0.90
1.7
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
26
185
1.42
0.90
1.1
1.1
u/ml
5.2
8.0
—
5
17
(3009871) Measles virus Ab [Titer] in Serum
6
29
2.08
0.89
1.5
1.6
—
—
—
0
0
(4268621)
12
71
1.70
0.89
1.8
2.4
—
—
—
0
0
(1002224) Polysomnography panel
42
325
1.31
0.88
1.0
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
16
103
1.56
0.88
1.4
4.2
%
2.3
1.3
0.48
11
87
(3000991) Gas panel - Venous blood
72
597
1.22
0.86
7.2
10.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
68
561
1.23
0.85
2.4
2.8
ng/l
235.3
187.0
0.30
58
516
(3022313) Gas panel - Capillary blood
39
300
1.31
0.85
2.9
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
29
213
1.37
0.85
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
104
1.55
0.85
1.2
1.1
u/ml
8.8
8.9
—
7
50
(3000012) Reticulocyte production index
6
31
1.94
0.84
3.0
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
39
301
1.31
0.84
2.6
2.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
6
113
0.53
0.83
2.2
3.3
u/ml
8.8
5.7
—
6
108
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
8
46
1.75
0.82
1.4
1.1
mg/l
47.1
43.7
—
8
35
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
8
46
1.75
0.82
1.1
1.1
mg/l
371.5
306.5
—
8
39
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
43
338
1.29
0.81
1.0
1.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
96
824
1.18
0.81
5.9
9.5
mmol/l
0.7
1.0
0.40
75
642
(3004588) Protein electrophoresis panel - Serum or Plasma
50
401
1.26
0.81
2.3
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
181
1.39
0.80
1.3
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
114
1.50
0.80
1.6
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
182
1.38
0.78
1.3
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
124
0.56
0.78
3.3
5.7
umol/l
342.0
371.0
—
7
108
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
100
0.50
0.77
4.4
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
37
288
1.30
0.76
1.9
2.0
ug/l
1.4
1.6
0.13
31
263
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
63
524
1.22
0.75
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
310
2894
1.11
0.75
2.7
2.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
100
1.51
0.73
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
28
211
1.34
0.72
1.1
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
48
391
1.24
0.70
1.3
1.3
u/ml
587.7
215.8
0.59
43
355
(3008401) Mugwort IgE Ab [Units/volume] in Serum
15
101
1.49
0.70
1.2
1.1
u/ml
0.6
2.7
—
5
37
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
87
752
1.17
0.70
2.2
1.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
237
2190
1.11
0.70
4.0
3.9
mg/mmol
6.9
9.0
0.39
162
1424
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
74
631
1.19
0.70
2.4
2.5
ug/l
5.9
8.4
1.10
65
569
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
33
257
1.29
0.69
1.6
1.7
nmol/l
38.2
38.3
0.01
33
248
(3008037) Lactate [Moles/volume] in Venous blood
10
157
0.63
0.69
4.3
2.9
mmol/l
1.5
1.5
—
10
151
(3005719) IgG [Mass/volume] in Serum or Plasma
58
485
1.21
0.67
4.3
2.6
g/l
10.2
10.6
0.38
53
443
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
43
1.63
0.67
1.0
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
28
1.79
0.66
1.2
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
20
145
1.39
0.66
3.1
2.2
%
15.3
16.2
—
9
70
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
78
1.55
0.65
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
180
1.34
0.65
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
44
1.60
0.65
1.0
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
46
378
1.23
0.64
1.7
1.8
g/l
1.1
1.5
1.27
40
349
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
112
1.44
0.63
2.0
1.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
75
649
1.17
0.61
1.6
2.3
g/l
0.2
0.2
0.20
70
609
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
51
1.57
0.60
1.5
2.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
122
1.40
0.60
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
83
727
1.16
0.59
1.2
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
87
765
1.15
0.58
1.9
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
13
89
1.47
0.58
2.1
2.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
35
1.72
0.57
1.0
1.3
u/l
160.3
675.1
—
6
30
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
6
35
1.72
0.57
1.0
1.0
—
4.4
—
0
5
(3038515) Glucose [Moles/volume] in Venous blood
10
149
0.67
0.57
4.3
3.0
mmol/l
7.9
7.9
—
10
144
(3011288) Drugs identified in Urine by Screen method
24
186
1.30
0.55
2.5
2.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
39
322
1.22
0.54
2.5
4.3
mmol/l
24.5
24.0
0.35
34
290
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
40
1.50
0.51
1.5
2.7
u/l
185.7
192.5
—
6
40
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
120
1089
1.12
0.51
1.9
1.8
—
—
—
0
0
(4094501)
26
206
1.27
0.51
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
20
153
1.31
0.50
1.2
1.2
mmol/l
3.5
3.9
1.68
20
145
(3036603) Volume of Urine
7
45
1.56
0.49
1.4
1.4
—
1573.5
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
41
345
1.20
0.48
1.8
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
309
1.21
0.47
1.6
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
68
1.48
0.47
2.1
5.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
68
1.48
0.47
1.5
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
48
1.46
0.47
1.3
2.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
77
1.43
0.45
1.7
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
85
763
1.13
0.45
1.9
1.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
60
526
1.15
0.45
2.8
2.8
e9/l
65.9
69.5
0.45
52
395
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
95
1.37
0.44
1.3
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
184
1.26
0.43
1.2
1.4
—
—
—
0
0
(44790047)
11
78
1.42
0.43
1.5
1.5
—
—
—
0
0
(44790048)
11
78
1.42
0.43
1.5
1.5
—
—
—
0
0
(44790049)
11
78
1.42
0.43
1.5
1.5
—
—
—
0
0
(44806118)
11
78
1.42
0.43
1.5
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
31
1.62
0.43
1.2
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
47
406
1.17
0.43
1.7
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
113
1.33
0.43
1.9
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
267
1.21
0.42
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
57
1.41
0.42
1.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
12
161
0.74
0.41
2.1
3.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
0
16
0.00
0.41
0.0
1.6
—
3.6
—
0
10
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
114
1.32
0.41
1.5
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
17
0.00
0.40
0.0
4.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
132
1.29
0.40
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
5
34
1.47
0.40
1.0
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
45
390
1.16
0.40
2.9
2.5
e6/l
0.4
0.2
0.25
45
382
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
2.3
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
88
1.37
0.40
1.6
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
12
88
1.37
0.40
1.3
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
101
0.69
0.39
1.6
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
193
0.77
0.39
1.1
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
(4024509)
5
35
1.43
0.39
1.4
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
35
1.43
0.39
1.2
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
71
1.41
0.39
4.6
4.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
187
1.24
0.39
1.3
1.4
ug/g
237.2
283.6
0.46
13
114
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
69
768
0.89
0.39
1.6
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
247
0.81
0.38
2.8
3.6
g/l
0.3
0.3
—
5
115
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
36
1.39
0.38
1.6
1.7
ug/l
10.4
11.3
—
5
29
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
69
1.31
0.37
1.3
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
37
1.35
0.37
5.4
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
125
1.28
0.37
1.2
1.2
u/ml
10.4
2.6
—
5
47
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
180
0.77
0.37
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
134
1.27
0.37
2.7
2.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
81
1.36
0.36
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
153
1435
1.08
0.36
1.8
1.7
pmol/l
428.4
31126250.8
1.46
137
1208
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
6
42
1.43
0.35
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
244
0.82
0.35
1.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
134
0.74
0.35
1.7
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
27
227
1.20
0.35
3.2
9.2
mmol/l
1.2
1.3
0.16
22
196
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
100
1.30
0.33
1.8
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
109
1.29
0.33
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
6
46
1.31
0.33
1.3
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
285
0.84
0.33
2.5
1.7
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
155
1.23
0.32
2.1
2.3
u/l
9051.0
2750.8
—
7
65
(21494890) Protein electrophoresis panel - 24 hour Urine
10
74
1.36
0.32
1.4
2.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
69
628
1.11
0.32
1.9
1.9
—
—
—
0
0
(4306422)
13
101
1.29
0.32
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
16
129
1.24
0.30
1.6
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
15
184
0.81
0.28
1.1
1.2
—
69.4
—
0
16
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
223
1.17
0.28
3.1
2.9
u/ml
0.3
0.3
0.28
17
125
(3013139) Helicobacter pylori Ag [Presence] in Stool
47
422
1.12
0.28
1.3
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
85
1.30
0.28
2.3
2.2
pg
33.4
32.7
0.27
11
85
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
32
280
1.15
0.28
1.7
1.9
—
—
—
0
0
(4062490)
8
63
1.27
0.27
1.3
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
67
1.20
0.26
1.1
1.9
—
—
—
0
0
(4146454)
5
71
0.70
0.26
2.6
2.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
71
0.70
0.26
1.2
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
75
1.20
0.25
1.1
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
1.9
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
75
1.20
0.25
1.1
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
105
1.24
0.25
1.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
17
142
1.20
0.24
3.2
4.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
76
1.19
0.24
1.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
76
1.19
0.24
1.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
76
1.19
0.24
1.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
76
1.19
0.24
1.1
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
124
1.21
0.24
1.6
2.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
190
1.16
0.23
2.1
2.3
ug/min
421.1
162.3
0.46
13
118
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
189
0.84
0.22
1.3
1.3
miu/ml
85.2
245.8
—
7
90
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(44813793)
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
33
367
0.90
0.21
3.2
3.2
mmol/l
24.6
24.9
0.24
33
355
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.0
—
3.4
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
6.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
12
0.00
0.21
0.0
9.7
—
6.1
—
0
12
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.8
—
36.4
—
0
5
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
28
314
0.89
0.21
1.4
1.7
mg/l
1.9
5.1
1.00
19
219
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
80
1.25
0.20
1.7
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
14
0.00
0.20
0.0
5.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
14
0.00
0.20
0.0
4.0
—
828.8
—
0
14
(3019060) Gas panel - Arterial blood
53
491
1.08
0.19
3.0
6.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
6
51
1.18
0.19
4.3
1.8
umol/l
7.0
4.7
—
6
39
(3004616) Nuclear Ab [Presence] in Serum
6
51
1.18
0.19
1.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
232
1.12
0.18
2.4
2.7
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
143
0.84
0.18
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
143
0.84
0.18
1.2
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
112
1173
0.95
0.18
1.6
1.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
36
328
1.10
0.18
3.8
3.4
%
52.4
52.0
0.03
36
321
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
119
1.18
0.17
1.8
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
403
0.91
0.17
2.0
1.6
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
7
63
1.11
0.17
1.0
1.1
—
197.3
—
0
11
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
70
0.71
0.16
2.8
3.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
120
1152
1.05
0.16
3.0
3.6
mmol/l
0.8
0.8
0.01
111
1089
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
77
811
0.94
0.16
1.4
1.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
8
71
1.13
0.16
1.1
1.1
—
0.7
—
0
17
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
8
71
1.13
0.16
2.6
2.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
24
266
0.90
0.16
2.0
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
76
0.79
0.15
1.8
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
140
1.15
0.15
1.1
1.4
—
—
—
0
0
(4035726)
60
635
0.94
0.15
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
95
910
1.05
0.14
1.4
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
89
0.78
0.14
1.9
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
160
1.13
0.14
1.7
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
80
837
0.95
0.14
4.6
4.2
%
32.1
31.9
0.05
63
551
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
27
294
0.92
0.13
1.3
1.9
g/l
1.8
1.5
0.30
20
247
(3019309) Folate [Moles/volume] in Red Blood Cells
121
1170
1.04
0.13
1.8
1.7
nmol/l
1255.7
1157.2
0.56
94
897
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
74
707
1.05
0.13
2.0
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
85
1.18
0.12
4.2
2.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
114
1.14
0.12
3.2
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
18
163
1.11
0.11
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
45
1.11
0.10
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
51
533
0.95
0.09
1.5
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
97
1.14
0.09
2.1
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
58
1.03
0.08
1.5
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
3.0
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
3.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
62
0.81
0.08
3.0
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
65
0.77
0.08
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
65
1.08
0.08
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
67
1.05
0.08
2.1
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
72
0.83
0.07
1.2
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
72
0.83
0.07
1.0
1.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
74
1.08
0.07
2.5
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
13
143
0.91
0.07
1.3
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
67
649
1.03
0.07
2.1
2.5
u/l
32.5
37.9
0.72
53
560
(3035637) Corticotropin [Mass/volume] in Plasma
8
77
1.04
0.07
1.1
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
68
659
1.03
0.07
2.9
3.8
mmol/l
2.1
1.8
0.23
55
510
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
78
1.03
0.07
1.0
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
83
0.84
0.07
1.6
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
9
84
1.07
0.07
1.0
2.1
—
1370.0
—
0
8
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
9
85
1.06
0.07
4.7
6.7
mg/l
10.7
11.6
—
9
80
(3023511) Choriogonadotropin [Units/volume] in Urine
9
88
1.02
0.07
1.7
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
91
0.88
0.06
1.6
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
42
437
0.96
0.06
1.1
1.2
iu/ml
198.5
145.9
0.21
15
171
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
101
0.89
0.06
1.8
3.0
%
13.1
13.0
—
9
101
(1761482) Bacteria [#/volume] in Urine by Culture
20
188
1.07
0.05
3.9
4.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
90
1.11
0.05
1.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
10
90
1.11
0.05
1.2
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
465
1.03
0.05
1.5
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
75
733
1.03
0.05
2.1
2.7
%
1.6
1.8
0.69
69
647
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
159
1.07
0.05
2.6
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
86
874
0.98
0.03
1.3
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
118
0.93
0.02
1.5
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
81
799
1.02
0.02
2.2
3.0
umol/l
8.5
8.8
0.04
67
707
(3003327) Ova and parasites identified in Stool by Light microscopy
21
202
1.04
0.02
1.9
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
117
0.94
0.01
1.5
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
46
468
0.98
0.01
4.3
8.4
mmol/l
23.9
24.3
0.27
40
439
(3019225) pH of Specimen
64
633
1.01
0.01
3.4
4.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
11
116
0.95
0.00
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
12
126
0.95
0.00
1.2
1.4
u/l
28.6
35.0
0.12
12
103
(3018405) Lactate [Moles/volume] in Arterial blood
28
274
1.02
0.00
2.5
3.8
mmol/l
1.3
1.4
0.06
28
268
(3001019) Free T4 and TSH panel - Serum or Plasma
38
386
0.98
0.00
1.6
1.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
24
236
1.02
0.00
1.7
2.0
%
97.0
88.1
1.36
24
221
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
14
138
1.01
0.00
1.2
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
20
202
0.99
0.00
1.3
1.4
u/l
13.9
8.1
0.84
20
165
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
109
1.01
0.00
2.9
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
181
0.99
0.00
1.2
1.2
—
—
—
0
0
(4034850)
26
265
0.98
0.00
6.6
8.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
165
1.03
0.00
2.2
1.7
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
14.1
—
0
5
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
58
0.86
0.00
4.6
4.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
18.8
—
0
5
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
111.0
—
0
5
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
17.0
—
0
5
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
133.8
—
0
5
(21494434) Karyotype in Bone marrow
6
63
0.95
0.00
1.3
1.3
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
9.8
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
150
1.00
0.00
1.1
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
69
0.87
0.00
1.8
1.6
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
59
1.02
0.00
1.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
33.9
—
0
9
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
21
210
1.00
0.00
1.9
2.3
%
186.3
199.8
0.32
21
200
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
82
0.98
0.00
2.0
2.5
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
2.2
1.7
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
0
9
0.00
0.00
0.0
7.0
—
30.7
—
0
9
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
68
0.88
0.00
1.5
2.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
8
83
0.96
0.00
1.1
1.4
u/l
33.6
23.6
—
8
70
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
0
8
0.00
0.00
0.0
1.4
—
864.3
—
0
8
(3025315) Body weight
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
70
1.00
0.00
1.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_LOOSEJOINT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_LOOSEJOINT | 0.759 [0.58, 0.99] | 0.038 |
| Birth year | 0.999 [0.99, 1.01] | 0.773 |
During the follow-up period (1.1.1998 — 31.12.2019), 54 out of 1209 females with M13_LOOSEJOINT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_LOOSEJOINT | 0.783 [0.66, 0.94] | 0.007 |
| Birth year | 0.985 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 138 out of 2346 males with M13_LOOSEJOINT died.
Mortality risk
Mortality risk for people of age
years, who have M13_LOOSEJOINT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.081% | 0.149% |
| 5 | 0.524% | 0.934% |
| 10 | 1.311% | 2.189% |
| 15 | 2.421% | 4.269% |
| 20 | 4.278% | 7.068% |
Relationships between endpoints
↥Index endpoint: M13_LOOSEJOINT – Loose body in joint
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data